Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SAGE Therapeutics
SAGE Therapeutics
[video+transcript]Here's Why Biotech Deals Are All the Rage Right Now
Motley Fool
Sat, 12/5/20 - 11:24 pm
biotech
M&A
Biogen
SAGE Therapeutics
Eli Lilly
Precision Biosciences
Merck
OncoImmune
Biogen bets $1.5B on Sage's once-failed depression drug
Fierce Biotech
Mon, 11/30/20 - 10:29 am
Biogen
SAGE Therapeutics
zuranolone
depression
Biogen stocks up on Sage's brain drugs in $3B deal
BioPharma Dive
Fri, 11/27/20 - 04:49 pm
Biogen
SAGE Therapeutics
brain diseases
Sage shares data on retreatment with depression drug zuranolone
Fierce Biotech
Thu, 10/15/20 - 12:02 pm
SAGE Therapeutics
zuranolone
clinical trials
major depressive disorder
Is There Any Hope Left for Sage Therapeutics?
Motley Fool
Tue, 06/9/20 - 11:02 am
SAGE Therapeutics
SAGE-217
SAGE-324
Sage to lay off half of workforce in cost-cutting retrenchment
BioPharma Dive
Tue, 04/7/20 - 07:47 pm
SAGE Therapeutics
layoffs
depression
Zulresso
Sage to run 3 new studies to save once-failed depression drug
Fierce Biotech
Wed, 03/18/20 - 10:14 am
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
Sage rethinks SAGE-217 program after phase 3 failure
Fierce Biotech
Thu, 02/27/20 - 10:32 am
SAGE Therapeutics
clinical trials
depression
SAGE-217
Here's Why Sage Therapeutics Lost 53.3% in December
Motley Fool
Mon, 01/6/20 - 11:28 pm
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Xconomy
Thu, 12/5/19 - 10:11 am
SAGE Therapeutics
clinical trials
SAGE-217
major depressive disorder
Sage's new drug starts slow, as Wall Street waits for depression data
Biopharma Dive
Wed, 11/13/19 - 11:25 pm
SAGE Therapeutics
postpartum depression
Zulresso
drug launches
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
Tue, 11/12/19 - 10:20 am
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
Upcoming events – Sage targets depression and Biogen aims for lupus
EP Vantage
Fri, 10/4/19 - 10:03 am
SAGE Therapeutics
SAGE-217
major depressive disorder
Biogen
BIIB059
lupus
Sage Therapeutics Updates Pipeline to Focus on Treatment-Resistant Depression
BioSpace
Thu, 07/25/19 - 07:07 pm
SAGE Therapeutics
treatment-resistant depression
SAGE-217
Marinus leaves the way clear for Sage
EP Vantage
Wed, 07/24/19 - 10:31 am
Marinus Pharma
SAGE Therapeutics
ganaxolone
clinical trials
postpartum depression
Sage strategy for postpartum depression drug Zulresso keys on patient support
Fierce Pharma
Mon, 07/1/19 - 12:03 pm
SAGE Therapeutics
postpartum depression
patients
Zulresso
2 Biotech Takeout Targets Perfect for Biogen
Motley Fool
Sat, 03/23/19 - 12:11 pm
Biogen
M&A
SAGE Therapeutics
Neurocrine Biosciences
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
Xconomy
Tue, 03/19/19 - 08:27 pm
SAGE Therapeutics
postpartum depression
Zulresso
brexanolone
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
With upcoming PDUFA, Sage proposes $500M follow-on
BioCentury
Mon, 02/25/19 - 11:26 pm
SAGE Therapeutics
postpartum depression
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »